Product logins

Find logins to all Clarivate products below.


Biosurgical Agents – Market Insights – Asia Pacific

The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical hemostats and high awareness among physicians about the clinical benefits of biosurgical agents in various procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the US from 2019 through 2033.

The Asia Pacific biosurgical agent market is highly competitive, dominated by MNCs.

Who are the top competitors in the Asia Pacific biosurgical agent market, and what factors contributed to their market position?

What recent changes have occurred in the competitive landscape of this market?

The Asia Pacific surgical hemostat market will grow over the forecast period.

What factors are driving the increasing adoption of surgical hemostats?

How will changing procedure volumes in certain surgical specialties affect market growth?

The utilization of biosurgical agents will vary across surgical specialties, influencing overall market trends.

Which surgical specialty type has the highest utilization of various types of biosurgical agents?

Which biosurgical agent materials are most popular and drive market growth within each specialty?

Table of contents


Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Pain Management Devices – Market Insights – United States
The US pain management device market is driven by continuous product innovation aimed at enhancing treatment efficacy and addressing new indications. Favorable clinical evidence and pain management…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…